Omnicell Inc
OMCL29.760USD
-1.250-4.03%
Cierre 08/01, 16:00（ET）Cotizaciones retrasadas 15 min
1.39BCap. mercado
65.81P/E TTM
Más Datos de Omnicell Inc Compañía
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Información de la empresa
Símbolo de cotizaciónOMCL
Nombre de la empresaOmnicell Inc
Fecha de salida a bolsaAug 08, 2001
Fundada en2000
Director ejecutivoMr. Randall A. Lipps
Número de empleados3670
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 08
Dirección4220 North Freeway
CiudadFORT WORTH
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal76137
Teléfono18774159990
Sitio Webhttps://www.omnicell.com/
Símbolo de cotizaciónOMCL
Fecha de salida a bolsaAug 08, 2001
Fundada en2000
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Randall A. Lipps
Mr. Randall A. Lipps
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
436.58K
-0.26%
Mr. Nnamdi Njoku
Mr. Nnamdi Njoku
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
90.93K
+69.90%
Mr. Robin Gene Seim
Mr. Robin Gene Seim
Independent Director
Independent Director
47.35K
+16.85%
Ms. Joanne B. Bauer
Ms. Joanne B. Bauer
Lead Independent Director
Lead Independent Director
44.90K
+18.74%
Mr. Bruce E. Scott
Mr. Bruce E. Scott
Independent Director
Independent Director
22.97K
+42.59%
Mr. Corey J. Manley
Mr. Corey J. Manley
Executive Vice President, Chief Legal and Administrative Officer
Executive Vice President, Chief Legal and Administrative Officer
21.27K
-1.54%
Mr. Edward Peter Bousa
Mr. Edward Peter Bousa
Independent Director
Independent Director
17.99K
+56.40%
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
17.18K
+70.20%
Mr. Kaushik (Bobby) Ghoshal
Mr. Kaushik (Bobby) Ghoshal
Independent Director
Independent Director
14.52K
+78.84%
Mr. Nchacha E. Etta
Mr. Nchacha E. Etta
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Randall A. Lipps
Mr. Randall A. Lipps
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
436.58K
-0.26%
Mr. Nnamdi Njoku
Mr. Nnamdi Njoku
Chief Operating Officer, Executive Vice President
Chief Operating Officer, Executive Vice President
90.93K
+69.90%
Mr. Robin Gene Seim
Mr. Robin Gene Seim
Independent Director
Independent Director
47.35K
+16.85%
Ms. Joanne B. Bauer
Ms. Joanne B. Bauer
Lead Independent Director
Lead Independent Director
44.90K
+18.74%
Mr. Bruce E. Scott
Mr. Bruce E. Scott
Independent Director
Independent Director
22.97K
+42.59%
Mr. Corey J. Manley
Mr. Corey J. Manley
Executive Vice President, Chief Legal and Administrative Officer
Executive Vice President, Chief Legal and Administrative Officer
21.27K
-1.54%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Connected devices, software licenses, and other
120.08M
44.53%
SaaS and Expert Services
63.12M
23.41%
Technical services
61.38M
22.76%
Consumables
25.09M
9.30%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
249.26M
92.43%
Rest of the World
20.40M
7.57%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Connected devices, software licenses, and other
120.08M
44.53%
SaaS and Expert Services
63.12M
23.41%
Technical services
61.38M
22.76%
Consumables
25.09M
9.30%
Estadísticas de accionistas
Actualizado: sáb., 17 de may
Actualizado: sáb., 17 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.81%
The Vanguard Group, Inc.
11.88%
State Street Global Advisors (US)
4.62%
Dimensional Fund Advisors, L.P.
4.02%
Victory Capital Management Inc.
3.59%
Other
61.08%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
14.81%
The Vanguard Group, Inc.
11.88%
State Street Global Advisors (US)
4.62%
Dimensional Fund Advisors, L.P.
4.02%
Victory Capital Management Inc.
3.59%
Other
61.08%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
50.19%
Investment Advisor/Hedge Fund
37.47%
Hedge Fund
8.64%
Research Firm
3.19%
Individual Investor
1.86%
Sovereign Wealth Fund
1.48%
Pension Fund
1.38%
Bank and Trust
0.91%
Family Office
0.10%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
679
49.31M
105.27%
-8.88M
2025Q1
708
50.20M
107.17%
-8.54M
2024Q4
716
48.64M
104.03%
-9.20M
2024Q3
742
47.70M
103.68%
-13.09M
2024Q2
766
48.23M
105.00%
-10.57M
2024Q1
786
47.95M
104.43%
-7.71M
2023Q4
812
47.51M
104.50%
-6.33M
2023Q3
817
49.57M
109.64%
-4.16M
2023Q2
820
48.12M
106.76%
-6.53M
2023Q1
823
48.10M
106.74%
-4.33M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
6.94M
14.81%
-199.83K
-2.80%
Mar 31, 2025
The Vanguard Group, Inc.
5.56M
11.88%
+11.69K
+0.21%
Mar 31, 2025
State Street Global Advisors (US)
2.17M
4.62%
-79.02K
-3.52%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.88M
4.02%
+241.88K
+14.73%
Mar 31, 2025
Victory Capital Management Inc.
1.68M
3.59%
+154.04K
+10.09%
Mar 31, 2025
Lazard Asset Management, L.L.C.
1.65M
3.51%
+3.79K
+0.23%
Mar 31, 2025
Champlain Investment Partners, LLC
1.45M
3.1%
-22.84K
-1.55%
Mar 31, 2025
Nikko Asset Management Co., Ltd.
1.41M
3%
-44.49K
-3.07%
Mar 31, 2025
D. E. Shaw & Co., L.P.
1.40M
2.98%
+455.16K
+48.39%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.17M
2.49%
+60.76K
+5.50%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: hace 3 horas
Actualizado: hace 3 horas
Nombre
Proporción
SPDR S&P Health Care Equipment ETF
1.77%
Texas Capital Texas Small Cap Equity Index ETF
1.54%
Global X HealthTech ETF
1.3%
Fidelity Digital Health ETF
1.27%
ROBO Global Healthcare Technology & Innovation ETF
1.06%
Invesco S&P SmallCap Health Care ETF
0.98%
Federated Hermes MDT Small Cap Core ETF
0.61%
Global X Robotics & Artificial Intelligence ETF
0.56%
Pacer US Small Cap Cash Cows Growth Leaders ETF
0.5%
Invesco NASDAQ Future Gen 200 ETF
0.44%
Ver más
SPDR S&P Health Care Equipment ETF
Proporción1.77%
Texas Capital Texas Small Cap Equity Index ETF
Proporción1.54%
Global X HealthTech ETF
Proporción1.3%
Fidelity Digital Health ETF
Proporción1.27%
ROBO Global Healthcare Technology & Innovation ETF
Proporción1.06%
Invesco S&P SmallCap Health Care ETF
Proporción0.98%
Federated Hermes MDT Small Cap Core ETF
Proporción0.61%
Global X Robotics & Artificial Intelligence ETF
Proporción0.56%
Pacer US Small Cap Cash Cows Growth Leaders ETF
Proporción0.5%
Invesco NASDAQ Future Gen 200 ETF
Proporción0.44%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
